SC 13G/A | 2024-03-07 | BlackRock Inc. | MERRIMACK PHARMACEUTICALS INC | 715,279 | 5.0% | EDGAR |
SC 13G/A | 2024-02-14 | 22NW Fund, LP | MERRIMACK PHARMACEUTICALS INC | - | 0.0% | EDGAR |
SC 13G | 2024-01-31 | BlackRock Inc. | MERRIMACK PHARMACEUTICALS INC | 743,623 | 5.2% | EDGAR |
SC 13D/A | 2024-01-25 | Newtyn Management, LLC | MERRIMACK PHARMACEUTICALS INC | 1,873,694 | 13.1% | EDGAR |
SC 13D/A | 2023-12-13 | Western Standard LLC | MERRIMACK PHARMACEUTICALS INC | 2,220,058 | 15.5% | EDGAR |
SC 13D/A | 2023-08-14 | Western Standard LLC | MERRIMACK PHARMACEUTICALS INC | 1,991,108 | 13.9% | EDGAR |
SC 13G/A | 2023-02-14 | Point72 Asset Management, L.P. | MERRIMACK PHARMACEUTICALS INC | 0 | 0.0% | EDGAR |
SC 13G/A | 2023-02-13 | 22NW Fund, LP | MERRIMACK PHARMACEUTICALS INC | 1,015,048 | 7.6% | EDGAR |
SC 13G | 2022-08-04 | Point72 Asset Management, L.P. | MERRIMACK PHARMACEUTICALS INC | 900,487 | 6.7% | EDGAR |
SC 13G/A | 2022-02-14 | 22NW, LP | MERRIMACK PHARMACEUTICALS INC | 1,241,896 | 9.3% | EDGAR |
SC 13G/A | 2022-02-14 | Nantahala Capital Management, LLC | MERRIMACK PHARMACEUTICALS INC | 569,971 | 4.3% | EDGAR |
SC 13G/A | 2021-02-12 | DIMENSIONAL FUND ADVISORS LP | MERRIMACK PHARMACEUTICALS INC | 550,539 | 4.1% | EDGAR |
SC 13G/A | 2021-02-12 | Nantahala Capital Management, LLC | MERRIMACK PHARMACEUTICALS INC | 751,843 | 5.6% | EDGAR |
SC 13G/A | 2021-02-12 | 22NW, LP | MERRIMACK PHARMACEUTICALS INC | 1,241,896 | 9.3% | EDGAR |
SC 13D/A | 2020-12-03 | Western Standard LLC | MERRIMACK PHARMACEUTICALS INC | 1,188,845 | 8.9% | EDGAR |
SC 13D/A | 2020-12-02 | Newtyn Management, LLC | MERRIMACK PHARMACEUTICALS INC | 1,519,107 | 11.4% | EDGAR |
SC 13D/A | 2020-07-27 | Newtyn Management, LLC | MERRIMACK PHARMACEUTICALS INC | 1,376,880 | 10.3% | EDGAR |
SC 13D/A | 2020-07-24 | Western Standard LLC | MERRIMACK PHARMACEUTICALS INC | 1,046,628 | 7.8% | EDGAR |
SC 13G/A | 2020-02-14 | BIOTECHNOLOGY VALUE FUND L P | MERRIMACK PHARMACEUTICALS INC | 0 | 0.0% | EDGAR |
SC 13G | 2020-02-14 | Nantahala Capital Management, LLC | MERRIMACK PHARMACEUTICALS INC | 747,635 | 5.6% | EDGAR |